Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.
Palisade Bio Q3 EPS $(0.08) Down From $0.42 YoY
Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.
Related Posts
The Hidden Puppeteer: Binance’s Alleged Covert Control Over Binance.US Accounts Draws Scrutiny
June 5, 10:13 AM
High-ranking Binance executive Guangying Chen, a trusted ally of Binance CEO Changpeng Zhao, was the principal controller of five bank accounts associated with the supposedly autonomous U.S. subsidiary of the colossal crypto exchange, Binance.US, according to disclosed bank records.
‘Carl Icahn Blasts Illumina For Nearly Doubling CEO’s Pay Despite Steep Drop In Market Value’ – CNBC
March 31, 12:24 PM
https://www.cnbc.com/2023/03/31/carl-icahn-blasts-illumina-ceo-pay-raise.html?utm_term=Autofeed&utm_medium=Social&utm_content=Main&utm_source=Twitter#Echobox=1680279561
Carl Icahn blasted Illumina for
Amazon’s Migrant Workers Confront Exploitation at Saudi Arabia Warehouse
October 11, 12:46 PM
Several Nepali workers at an Amazon.Com Inc (NASDAQ: AMZN)